The Link Between Allergic and Autoimmune Disorders: Shared Pathways

Medical researchers are challenging the long-held boundary between allergic conditions and autoimmune disorders, uncovering shared immune mechanisms that point toward a unified origin for both disease types.

Key Clinical Takeaways:
• Recent studies show a 49% higher hazard of autoimmune disease in patients diagnosed with atopic dermatitis.
• Researchers have identified epithelial barrier damage from everyday chemicals and pollutants as a potential shared trigger.
• Clinicians are increasingly exploring treatments that target overlapping inflammatory pathways, including medications utilizing interleukin-5 and Janus kinase signaling.

Overlapping Immune Dysfunction Challenges Separate Evaluations

For decades, medicine evaluated and treated allergic disorders and autoimmune conditions as opposing forms of immune dysfunction. Allergic reactions typically involve T-helper 2 (Th2) immune responses, while autoimmune diseases have been linked more closely to Th1 pathways. Growing evidence indicates this clinical distinction is overly simplistic, as both disease categories frequently coexist in patients and share underlying inflammatory pathways, genetic susceptibilities, and immune tolerance mechanisms.

According to Giuseppe Alvise Ramirez, an immunologist at Ospedale San Raffaele in Milan, Italy, this shift in understanding may redefine the purpose of treatment beyond inducing single-disease remissions. The realization has paved the way for repurposing medications developed for allergic conditions to treat autoimmune diseases, and vice versa.

Epidemiological Evidence Connects Atopic Dermatitis to Autoimmune Disease

Clinical data show how often these conditions overlap. A 2019 cross-sectional study in the United States found that adults with atopic dermatitis had a higher prevalence of autoimmune disorders than those without the condition, at 7.9% compared to 5.7%. A similar divergence appeared in children, at 2.0% versus 1.0%.

A subsequent systematic review and meta-analysis published in 2025 evaluated 26 studies and recorded a 49% higher hazard of autoimmune disease among patients with atopic dermatitis. The analyzed autoimmune conditions included rheumatoid arthritis, systemic lupus erythematosus, celiac disease, alopecia areata, Sjögren syndrome, and ulcerative colitis.

Further supporting these findings, a 2026 nationwide cohort study tracking more than 269,000 South Korean adults established associations between common allergic diseases—including asthma, allergic rhinitis, and atopic dermatitis—and six autoimmune outcomes: rheumatoid arthritis, Hashimoto’s thyroiditis, Graves’ disease, ankylosing spondylitis, ulcerative colitis, and systemic lupus erythematosus.

Epithelial Barrier Damage Emerges as a Driver of Immune Dysregulation

The convergence of these conditions points toward vulnerability in the protective cellular layer lining the skin, respiratory tract, and gastrointestinal system. Cezmi Akdis, director of the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland, formulated the epithelial barrier theory to explain this vulnerability. The theory proposes that pervasive substances like cleaning surfactants, air pollutants, microplastics, and food emulsifiers disrupt tight junctions connecting epithelial cells.

This disruption permits allergens, pollutants, and microbes to interact more readily with immune cells, triggering persistent inflammation and degrading the body’s natural tolerance mechanisms. Akdis recommends reducing unnecessary exposure to surfactants found in household cleaners, dishwasher detergents, and personal care products to limit this damage.

Clinical Practice Adapts to Shared Biomarkers

In clinical settings, specialists are adjusting diagnostic routines to account for these overlapping risks. Rita Kachru, section chief for clinical immunology and allergy at UCLA Health in Los Angeles, routinely screens allergic disease patients for symptoms and family histories suggestive of autoimmunity by inquiring about gastrointestinal issues, unexplained rashes, recurrent fevers, and photosensitivity. Researchers continue to investigate shared pathways of immune dysregulation that could yield new biomarkers and therapeutic targets as the medical community moves toward integrated treatment strategies.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.